Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125726901 | 12572690 | 1 | I | 20160711 | 20160720 | 20160720 | EXP | LB-ROCHE-1794909 | ROCHE | 0.00 | A | M | Y | 80.00000 | KG | 20160720 | MD | LB | LB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125726901 | 12572690 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Unknown | 125085 | 5 | MG/KG | |||||||||
125726901 | 12572690 | 2 | SS | LEUCOVORIN. | LEUCOVORIN | 1 | Unknown | 0 | |||||||||||
125726901 | 12572690 | 3 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | 0 | |||||||||||
125726901 | 12572690 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125726901 | 12572690 | 1 | Colorectal cancer metastatic |
125726901 | 12572690 | 2 | Colorectal cancer metastatic |
125726901 | 12572690 | 3 | Colorectal cancer metastatic |
125726901 | 12572690 | 4 | Colorectal cancer metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125726901 | 12572690 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125726901 | 12572690 | Disease progression | |
125726901 | 12572690 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |